Valuation: SMAIO

Market Cap 4.37Cr 5.1Cr 4.09Cr 3.74Cr 7.03Cr 488.58Cr 7.12Cr 48Cr 19Cr 245.22Cr 19Cr 19Cr 811.57Cr P/E 2026 *
-19.9x
P/E 2027 * 194x
Enterprise Value 4.22Cr 4.93Cr 3.95Cr 3.61Cr 6.78Cr 471.81Cr 6.87Cr 47Cr 18Cr 236.81Cr 19Cr 18Cr 783.72Cr EV / Sales 2026 *
3.84x
EV / Sales 2027 * 2.68x
Free-Float
14.95%
Yield 2026 *
-
Yield 2027 * -
1 day+2.11%
1 week+1.57%
Current month+0.78%
1 month-6.95%
3 months-13.78%
6 months+15.82%
Current year+24.16%
1 week 7.54
Extreme 7.54
7.76
1 month 7.02
Extreme 7.02
8.4
Current year 6
Extreme 6
9.1
1 year 5.9
Extreme 5.9
9.1
3 years 2.25
Extreme 2.25
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 29/12/2008
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2020
Director TitleAgeSince
Chairman - 30/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+2.11%+1.57%+22.20%+218.03% 5Cr
+0.88%+3.84%+77.96%+129.75% 1,10900Cr
+1.07%+3.11%+51.11%+56.67% 64TCr
+1.20%+5.64%+26.68%+76.48% 46TCr
+1.02%+3.67%+43.14%+47.27% 37TCr
+0.85%+2.97%+24.48%+42.54% 30TCr
+1.26%+4.54%+2.20%+14.84% 26TCr
+1.88%+5.14%+48.20%+67.80% 23TCr
+1.59%+0.87%-12.95%-51.91% 20TCr
+1.87%+5.78%+23.07%+92.57% 18TCr
Average +1.06%+2.65%+30.61%+69.40% 37.61TCr
Weighted average by Cap. +0.51%+3.26%+44.79%+72.24%

Financials

2026 *2027 *
Net sales 1.1Cr 1.28Cr 1.03Cr 94.17L 1.77Cr 122.96Cr 1.79Cr 12Cr 4.74Cr 62Cr 4.82Cr 4.72Cr 204.24Cr 1.6Cr 1.87Cr 1.5Cr 1.37Cr 2.57Cr 178.85Cr 2.6Cr 18Cr 6.89Cr 90Cr 7.01Cr 6.86Cr 297.08Cr
Net income -22.5L -26.28L -21.04L -19.26L -36.16L -25Cr -36.63L -2.49Cr -96.94L -13Cr -98.64L -96.5L -42Cr 2L 3L 2L 2L 4L 2.79Cr 4L 27.64L 10.77L 1.4Cr 10.96L 10.72L 4.64Cr
Net Debt -15L -17.52L -14.03L -12.84L -24.11L -17Cr -24.42L -1.66Cr -64.62L -8.42Cr -65.76L -64.33L -28Cr -9L -10.51L -8L -8L -14.47L -10Cr -14.65L -99.49L -38.77L -5.05Cr -39.46L -38.6L -17Cr
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
21/26/21 €7.760 +2.11% 447
20/26/20 €7.600 +0.26% 120
19/26/19 €7.580 +0.53% 5
18/26/18 €7.540 0.00% 922
17/26/17 €7.540 -1.31% 1,318
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
7.760EUR
Average target price
8.200EUR
Spread / Average Target
+5.67%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock